Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis

Research output: Contribution to journalArticle

Authors

Colleges, School and Institutes

Abstract

Anti-CCP antibodies are very specific for the development of RA in patients with very early synovitis.[1] Their predictive value is underscored by their high weighting in an algorithm validated in patients with undifferentiated synovitis

Details

Original languageEnglish
Pages (from-to)627-628
Number of pages2
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number3
Publication statusPublished - 20 Oct 2009